A complementary nootropic stack from Russian peptide research pairing Selank's anxiolytic and stress-modulating properties with Semax's BDNF-upregulating and cognitive-enhancing effects. Selank reduces anxiety and stabilises mood via modulation of the enkephalin system and GABAergic tone, while Semax enhances focus, memory consolidation, and neuroprotection through BDNF and ACTH-related pathways. Together they aim to eliminate cognitive friction while amplifying mental output.
Mechanism
Upregulates BDNF synthesis and mimics ACTH-derived peptide activity to enhance focus, working memory, and neuroprotection — the primary cognitive performance driver of this stack.
Modulates the enkephalin system and GABAergic tone to reduce anxiety and psychological stress without sedation, creating the calm mental baseline on which Semax's cognitive enhancement can operate most effectively.
Dual-pathway activation
Semax × Selank
Both are Russian-developed synthetic peptides with a history of clinical use in Russia and Eastern Europe; neither is FDA-approved in the United States. Independent Western replication of their safety and efficacy data is limited. Both are typically administered intranasally. Potential interactions with psychiatric medications, anxiolytics, or other nootropics are not characterised; use alongside such agents warrants medical supervision.
Russian-language journal, single institute, limited independent Western replication
Semax, an Analog of ACTH(4-10) with Cognitive Effects, Regulates BDNF and tPA Expression
Effect of Selank on anxiety and depression
Dihexa is researched as a potent hepatocyte growth factor (HGF/c-Met) modulator that promotes synaptogenesis and spatial memory. Semax, an ACTH analog, is investigated for BDNF upregulation and neuroprotective signaling in the brain. The combination is explored for its complementary routes to memory consolidation and cognitive resilience.
A sleep and stress-reduction stack combining DSIP's direct sleep-promoting and sleep architecture-improving properties with Selank's daytime anxiolytic and mood-stabilising effects. DSIP is proposed to increase slow-wave delta sleep and normalise circadian sleep patterns by modulating hypothalamic sleep-wake centres, while Selank reduces anxiety, cortisol reactivity, and cognitive stress load that often prevents sleep onset. The combination targets both the quality of sleep and the psychological barriers to achieving it.
⚠ Educational Use OnlyPeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Free newsletter
The Peptide Research Digest
Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.